Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Plos Pathogens|March 2, 2021
Correction: RV144 HIV-1 vaccination impacts post-infection antibody responsesThembi Mdluli, Ningbo Jian, Bonnie Slike, et al.
Iscience|October 1, 2024
SARS-CoV-2 ferritin nanoparticle vaccines produce hyperimmune equine sera with broad sarbecovirus activityElizabeth J Martinez, William C Chang, Wei-Hung Chen, et al.
Plos Pathogens|December 8, 2020
RV144 HIV-1 vaccination impacts post-infection antibody responsesThembi Mdluli, Ningbo Jian, Bonnie Slike, et al.
Vaccines|October 28, 2025
Production of Clinical-Grade SARS-CoV-2 Spike Ferritin Nanoparticle Protein Immunogen by Transient TransfectionAgnes Hajduczki, William C Chang, Rafael De La Barrera, et al.
Emerging Microbes & Infections|December 13, 2023
Lassa virus in novel hosts: insights into the epidemiology of lassa virus infections in southern NigeriaAnise Nkenjop Happi, Olusola Akinola Ogunsanya, Akeemat Opeyemi Ayinla, et al.
Virus Evolution|September 17, 2021
RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infectionEric Lewitus, Eric Sanders-Buell, Meera Bose, et al.
JCI Insight|January 31, 2020
HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functionsDavid Easterhoff, Justin Pollara, Kan Luo, et al.
Nature Communications|January 3, 2024
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaquesRajeshwer S Sankhala, Kerri G Lal, Jaime L Jensen, et al.
Pageof 13